title: Heart disease in thalassemia intermedia: a review of the underlying pathophysiology.
abstract: Heart disease is the leading cause of mortality and one of the main causes of morbidity in beta-thalassemia. The clinical spectrum of the thalassemia syndrome ranges from the severe, transfusion--dependent thalassemia major and the asymptomatic carrier state. Thalassemia intermedia represents a milder form and is usually transfusion-independent. Two main factors determine cardiac disease in this form. One is the high output state that results from chronic tissue hypoxia and from hypoxia-induced compensatory reactions. The other is the vascular involvement that leads to an increased pulmonary vascular resistance and an increased systemic vascular stiffness. Valvular abnormalities and iron overload also contribute to a less extent. As a result, both right and left ventricles have to maintain a high cardiac output level through a stiff vascular bed. Right heart involvement with age-related pulmonary hypertension followed by congestive heart failure dominates the clinical picture. Although the left heart is also affected, systolic left ventricular function is usually preserved but this may also be decompensated under conditions characterized by excessive cardiac work load.
authors.affiliation: First Dept. of Internal Medicine, University of Athens Medical School, Laiko Hospital, Athens, Greece. aaisopos@cc.uoa.gr
authors.forename: Athanasios
authors.initials: A
authors.lastname: Aessopos
authors.forename: Maria
authors.initials: M
authors.lastname: Kati
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Farmakis
mesh_terms: D002302:Cardiac Output; D015687:Cell Hypoxia; D004547:Elastic Tissue / Q000473:pathology; D004730:Endothelium, Vascular / Q000473:pathology; D004920:Erythropoiesis; D005319:Fetal Hemoglobin / Q000378:metabolism; D006331:Heart Diseases / Q000209:etiology* / Q000503:physiopathology; D006333:Heart Failure / Q000209:etiology / Q000503:physiopathology; D006349:Heart Valve Diseases / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology / Q000503:physiopathology; D000860:Hypoxia / Q000209:etiology; D007408:Intestinal Absorption; D007501:Iron / Q000378:metabolism; D019190:Iron Overload / Q000209:etiology / Q000503:physiopathology; D019266:Iron, Dietary / Q000493:pharmacokinetics; D009569:Nitric Oxide / Q000378:metabolism; D019851:Thrombophilia / Q000209:etiology / Q000503:physiopathology; D014664:Vasodilation; D016277:Ventricular Function, Left; D017086:beta-Thalassemia / Q000150:complications* / Q000503:physiopathology
chemical_list: D019266:Iron, Dietary; D009569:Nitric Oxide; D005319:Fetal Hemoglobin; D007501:Iron